Newsletter | July 26, 2021

07.26.21 -- In Pharma, It's Not About Location; It's About Talent

Capitalization, Coaching, And Clarity Are Keys To Success

Throughout my career, I have employed the following guiding principles to advance treatment options for patients: capitalization is king, hire the right people, and be decisive and humble.

Coming Out Of Stealth Mode: What To Know And Do

Five CEOs discuss their experiences with stealth mode transitions. They address when and how a company should turn away from that introspective state and show itself to the world.

Hiring For Talent, Not Geography

It is more important to build a team of talented individuals, united around a common goal, than to narrow in on the location where those people are based.

From Academia To The Biopharma C-Suite

We thought an executive virtual roundtable topic of, “From Academia To The Biopharma C-Suite,” would help you learn from these executives who took a less traditional path to becoming a biopharmaceutical leader. Perspectives are provided by Rahul Aras, Ph.D., CEO, Iterion Therapeutics; Steffen Mueller, Ph.D., cofounder and CSO, Codagenix; and Prem Premsrirut, M.D., Ph.D., CEO, Mirimus.

Web-Exclusive Content
Qualification Considerations For A “Factory-in-a-Box”

The cell therapy market is rapidly expanding into a multibillion-dollar industry, but its production is cost-prohibitive due to the limited manufacturing space and number of personnel required, while capacity is not easily scalable and is limited by processing time. Enter the "factory-in-a-box," which can be a game-changer for the industry.

July 2021 Digital Edition

Inside you will find more on:

  • The Future Is In Womens' Health
  • Decentralized Trials: A Blessing Or A Curse
  • CEO Corner
  • The Transformation Of Travere Therapeutics

View the digital edition.

Contribute To Life Science Leader
Article Submission Guidelines

Think you have a good idea for an article that Life Science Leader readers would find valuable? Read these guidelines first before submitting your idea or your article to our editorial director.